Table 2 Occurrence of clinical adverse events
Total (n = 569) | Cirrhosis (n = 197) | Non-cirrhosis (n = 372) | P value | |
|---|---|---|---|---|
Decompensated cirrhosis | 42 (7.4) | 31 (15.7) | 11 (3.0) | < 0.001 |
ACLF | 10 (1.8) | 7 (3.6) | 3 (0.8) | 0.018 |
HCC | 9 (1.6) | 7 (3.6) | 2 (0.5) | 0.006 |
Total (n = 569) | Cirrhosis (n = 197) | Non-cirrhosis (n = 372) | P value | |
|---|---|---|---|---|
Decompensated cirrhosis | 42 (7.4) | 31 (15.7) | 11 (3.0) | < 0.001 |
ACLF | 10 (1.8) | 7 (3.6) | 3 (0.8) | 0.018 |
HCC | 9 (1.6) | 7 (3.6) | 2 (0.5) | 0.006 |